AJAleksandar Jankovic

Aleksandar Jankovic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksandar Jankovic has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Nada Dimkovic

    Clinical Department for Nephrology with Dialysis, University Medical Center Zvezdara, Belgrade, Serbia

    3 shared publications
  • Petar Djuric

    Clinical Department for Nephrology with Dialysis, University Medical Center Zvezdara, Belgrade, Serbia

    3 shared publications
  • Ana Bulatovic

    Clinical Department for Nephrology with Dialysis, University Medical Center Zvezdara, Belgrade, Serbia

    2 shared publications
  • Georg Schlieper

    Department of Nephrology and Clinical Immunology, Uniklinik RWTH Aachen, Aachen, Germany

    2 shared publications
  • Jelena Tosic-Dragovic

    Clinical Department for Nephrology with Dialysis, University Medical Center Zvezdara, Belgrade, Serbia

    2 shared publications
  • Jovan Popovic

    Clinical Department for Renal Diseases, Zvezdara University Medical Center, Dimitrija Tucovica 161, 11000, Belgrade, Serbia

    2 shared publications

Latest Publications

  • Open Access

    Onset of Microscopic Polyangiitis in Binephrectomied Patient on Chronic Hemodialysis—Case Report

    by Aleksandar Jankovic, Vesna Maslarevic-Radovic, Petar Djuric, Jelena Tosic-Dragovic, Ana Bulatovic, Nikola Simovic, Milos Mitrovic, Verica Stankovic-Popovic, Vesna Dopudja-Pantic, Snezana Arandjelovic, et al.

    Introduction: Microscopic polyangitis (MPA) is one of the causes of the pulmonary-renal syndrome associated with elevated nonspecific markers of inflammation and ANCA-positivity in 50-75%. De novo occurrence of the disease in patients on chronic hemodialysis has not been described. Case presentation: We presented patient who developed MPO-ANCA-associated MPA with lung and musculoskeletal involvement after four years on regular hemodialysis (HD) due to bilateral nephrectomy. After excluding the other causes of MPO-ANCA positivity, diagnosis was confirmed even without renal biopsy. Patient received standard immunosuppression therapy and he is still in remission after 27 months. Conclusion: The onset of immune-mediated disease could be observed even after introduction of renal replacement therapy (RRT) which may be a diagnostic problem. Early recognition and traditional immunosuppressive regiment may provide successful outcome.

  • Calcification in arteriovenous fistula blood vessels may predict arteriovenous fistula failure: a 5-year follow-up study

    by Aleksandar Jankovic, Tatjana Damjanovic, Zivka Djuric, Jelena Marinkovic, Georg Schlieper, Petar Djuric, Jelena Tosic Dragovic, Ana Bulatovic, Milos Mitrovic, Jovan Popovic, et al.

    Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis. The impact of vascular calcification process on AVF survival remains unclear and results of several studies about this issue are controversial. In the light of the new knowledge about the different susceptibility for calcification process in different blood vessels, the aim of our study was to analyze whether the calcification of AVF-blood vessels may have an impact on AVF longevity.


  • Open Access

    Impact of Vascular Calcifications on Arteriovenous Fistula Survival in Hemodialysis Patients: A Five-Year Follow-Up

    by Aleksandar Jankovic, Tatjana Damjanovic, Zivka Djuric, Jelena Marinkovic, Georg Schlieper, Jelena Tosic-Dragovic, Petar Djuric, Jovan Popovic, Juergen Floege, Nada Dimkovic

    Background/Aims: Vascular calcifications are frequently found among dialysis patients, and the calcification process may influence the patient's outcome. The aim of the present study was to determine the role that vascular calcifications may have on autologous arteriovenous fistula (AVF) survival. Methods: This study included 90 patients (49 males, mean age 62 ± 11) with a native AVF treated by chronic hemodialysis (HD) for more than one year. The overall vascular calcification scores ranged from 0-11 (Adragao score + vascular access calcification score); patients were categorized into mild (score 0-3; n = 36), moderate (score 4-7; n = 24) and severe (score 8-11; n = 30) calcification groups. AVF survival was then followed for 5 years after calcification measurement or until the patient's death/transplantation. Results: Patients with more pronounced vascular calcifications were more frequently diabetic and male. Multiple linear regression analysis showed a significant relationship between calcification score and male gender, diabetes mellitus, previous duration of AVF, low dialysis flow rate and intact parathormone (iPTH) values. After multivariate adjustment for basal differences, Cox proportional analysis revealed a graded impact of calcification scores on AVF failure: moderate scores (were associated with a hazard rate (HR) of 3.82 (95% confidence interval (CI) 1.10-13.23) and severe scores with an HR of 4.65 (CI 0.97-22.38). Conclusion: Vascular calcifications are associated with worse survival of native arteriovenous hemodialysis fistulas.